Press Releases

Zero Gravity Solutions, Inc. Announces Appointment of Andrew E. Koopman as President and Chief Executive Officer of Zero Gravity Life Sciences, Inc.

BOCA RATON, Fla.— (July 13, 2016),– Zero Gravity Solutions, Inc. (“ZGSI” or the “Company”) (Pink Sheets: ZGSI), an agricultural biotechnology public company commercializing its technology derived from and designed for Space with significant applications for agriculture on Earth, announced that Andrew E. Koopman has been appointed President and Chief Executive Officer of Zero Gravity Life Sciences, Inc. (ZGLS). ZGLS, a wholly-owned subsidiary of ZGSI, is focused on expanding the Company’s intellectual property related to life sciences. The IP was developed from research conducted on the International Space Station enabled by six NASA missions.

Mr. Koopman’s initial focus is to coordinate the activities of the Company’s expanded scientific team, including our research activities with NASA Ames under the previously announced Space Act Agreement. Mr. Koopman’s responsibilities also include technical support and research to diversify the BAM-FX™ product line, grant and IP strategies and execution.

“Andrew’s background as Director of New Ventures at New York University’s (NYU) Office of Industrial Liaison provides our Company with the unique skill sets required to develop intellectual property into successful commercial business opportunities,” stated Harvey Kaye, ZGSI’s Chairman of the Board.

“After serving as a Scientific Advisor for Zero Gravity Solutions for the previous two years and observing the progress made in development and commercialization of the BAM-FX™ technology, I am excited to join such an extraordinary team. I look forward to leveraging my relationships and applying my experience in the translation of scientific achievements and intellectual property as contribution towards both the achievement of ZGSI’s critical mission and the enhancement of shareholder value”, stated Andrew Koopman, ZGLS’s new President and Chief Executive Officer.

 

About Zero Gravity Solutions, Inc.

Zero Gravity Solutions, Inc. www.zerogsi.com is an agricultural biotechnology public company commercializing its technology derived from and designed for Space with significant applications on Earth. These technologies are focused on providing valuable solutions to challenges facing world agriculture. ZGSI’s two primary categories of technologies aimed at sustainable agriculture are: 1) BAM-FX, a cost effective, ionic micronutrient delivery system for plants currently being introduced commercially into world agriculture by Zero Gravity’s wholly owned subsidiary BAM Agricultural Solutions and 2) Directed Selection™, utilized in the development and production, in the prolonged zero/micro gravity environment of the International Space Station, of large volumes of non-GMO, novel, patentable stem cells with unique and beneficial characteristics. 

Like us on Facebook
Follow us on Twitter

This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, acceptance of the Company’s products, increased levels of competition for the Company, new products and technological changes, the Company’s dependence on third-party suppliers, and other risks detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission.  Except as required by applicable law or regulation, Zero Gravity Solutions undertakes no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made.

Zero Gravity Solutions, Inc.
Harvey Kaye, Chairman
+1 561.416.0400
This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact Information

Zero Gravity Solutions, Inc.
190 NW Spanish River Blvd.
Boca Raton, FL 33431
USA

Telephone: +1 561-416-0400
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.